Diphenhydramine Hydrochloride; Ibuprofen Patent Expiration

Diphenhydramine Hydrochloride; Ibuprofen is Used for treating pain-associated sleep disturbances. It was first introduced by Haleon Us Holdings Llc in its drug Advil Pm on Dec 21, 2005. 4 different companies have introduced drugs containing Diphenhydramine Hydrochloride; Ibuprofen.


Diphenhydramine Hydrochloride; Ibuprofen Patents

Given below is the list of patents protecting Diphenhydramine Hydrochloride; Ibuprofen, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Advil Pm US8883849 Treatment of sleep disturbances Jan 17, 2022

(Expired)

Haleon Us Holdings
Advil Pm US9155718 Treatment of sleep disturbances Jan 17, 2022

(Expired)

Haleon Us Holdings



Diphenhydramine Hydrochloride; Ibuprofen's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Diphenhydramine Hydrochloride; Ibuprofen Generic API Manufacturers

Several generic applications have been filed for Diphenhydramine Hydrochloride; Ibuprofen. The first generic version for Diphenhydramine Hydrochloride; Ibuprofen was by Bionpharma Inc and was approved on Nov 22, 2010. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Feb 14, 2019.

Given below is the list of companies who have filed for Diphenhydramine Hydrochloride; Ibuprofen generic, along with the locations of their manufacturing plants worldwide.